"Many New mRNA Applications." This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even cancer.
See omnystudio.com/listener for privacy information.
Fler avsnitt av Bloomberg Businessweek
Visa alla avsnitt av Bloomberg BusinessweekBloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
